Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Related articles

VOLUME 41 , ISSUE 2ESP ( Apr-2013, 2013 ) > List of Articles

REVIEW ARTICLE

Diagnóstico y Tratamiento de los Pacientes con Enfermedad de la Superficie Ocular y Glaucoma

Gemma Caterina Maria ROSSI

Citation Information : ROSSI GC. Diagnóstico y Tratamiento de los Pacientes con Enfermedad de la Superficie Ocular y Glaucoma. 2013; 41 (2ESP):2-5.

DOI: 10.5005/hos-10101-41201

Published Online: 01-10-2020

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

PDF Share
  1. Rolando M, Geerling G, Dua HS et al Emerging treatment paradigms of ocular surface disease: proceedings of the Ocular Surface Workshop. Br J Ophthalmol 2010, 94(suppl) 1:i1-i9.
  2. Report of the International Dry Eye Workshop (DEWS). The epidemiology dry eye disease. Ocul Surf 2007; 5: 27-41.
  3. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118: 1264-1268.
  4. EGS Terminology and guidelines for glaucoma, 3rd ed. Savona: Dogma, 2008:95-96.
  5. Baudouin C, Pisella PJ, Fillacier K et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999; 106:556-563.
  6. Tsai JH, Derby E, Holland EJ, Khatana AK. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 2006;25:530-532.
  7. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008;17:350-355.
  8. Rossi GC, Tinelli C, Pasinetti GM et al. Dry eye syndromerelated quality of life in glaucoma patients. Eur J Ophthalmol 2009; 4:572-579.
  9. Fechtner RD, Godfrey DG, Budenz D et al. Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications. Cornea 2010; 29:618-621.
  10. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003; 44: 4753-4761.
  11. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23: 762-770.
  12. Atkinson MJ, Stewart WC, Fain JM, Stewart JA, Dhawan R, Mozaffari E, Lohs J. A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP). Health and quality life outcomes 2003; 1: 67.
  13. Lee BL, Gutierrez P, Gordon M, Wilson MR, Cioffi GA, Ritch R, Sherwood M, Mangione CM. The Glaucoma symptom scale. A brief index of glaucoma specific symptoms. Arch Ophthalmol 1998; 116: 861-866.
  14. Ruiz MA, Pardo A, Martinez de la Casa JM, Polo V, Esquirol J, Soto J. Cultural adaptation and validation into Spanish of the Glaucoma Symptom Scale. Med Clin 2009; 132:89-97.
  15. Rossi GC, Pasinetti GM, Scudeller L, et al. The Italian version of the Glaucoma Symptom Scale questionnaire: Translation, Validation and Reliability. J Glaucoma 2012, in press.
  16. Bron AJ, Evans VE, Smith JA Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640-49.
  17. Jaenen N, Baudouin C, Pouliquen P, et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007;17:341-349.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.